TY - JOUR
T1 - Therapeutics targeting the inflammasome after central nervous system injury
AU - de Rivero Vaccari, Juan Pablo P
AU - Dalton Dietrich, W.
AU - Keane, Robert
PY - 2015/3/23
Y1 - 2015/3/23
N2 - Innate immunity is part of the early response of the body to deal with tissue damage and infections. Because of the early nature of the innate immune inflammatory response, this inflammatory reaction represents an attractive option as a therapeutic target. The inflammasome is a component of the innate immune response involved in the activation of caspase 1 and the processing of pro-interleukin 1β. In this article, we discuss the therapeutic potential of the inflammasome after central nervous system (CNS) injury and stroke, as well as the basic knowledge we have gained so far regarding inflammasome activation in the CNS. In addition, we discuss some of the therapies available or under investigation for the treatment of brain injury, spinal cord injury, and stroke.
AB - Innate immunity is part of the early response of the body to deal with tissue damage and infections. Because of the early nature of the innate immune inflammatory response, this inflammatory reaction represents an attractive option as a therapeutic target. The inflammasome is a component of the innate immune response involved in the activation of caspase 1 and the processing of pro-interleukin 1β. In this article, we discuss the therapeutic potential of the inflammasome after central nervous system (CNS) injury and stroke, as well as the basic knowledge we have gained so far regarding inflammasome activation in the CNS. In addition, we discuss some of the therapies available or under investigation for the treatment of brain injury, spinal cord injury, and stroke.
UR - http://www.scopus.com/inward/record.url?scp=84930260386&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84930260386&partnerID=8YFLogxK
U2 - 10.1016/j.trsl.2015.05.003
DO - 10.1016/j.trsl.2015.05.003
M3 - Article
C2 - 26024799
AN - SCOPUS:84952639919
JO - Translational Research
JF - Translational Research
SN - 1931-5244
ER -